July 18, 2024 | Research Guide
Oncology Research Applications for Unbiased Proteomics
Cancer continues to rise globally with the World Health Organization predicting that by 2050 there will be over 35 million new cancer cases annually.
This research guide explores the opportunities for unbiased proteomics to help advance oncology research in biomarker discovery and diagnostic development, precision oncology and personalized medicine, and disease mechanism research and drug target discovery.
See how Seer’s Proteograph™ Product Suite is closing the cancer research gap, enabling oncology researchers to expand their -omics techniques by exploring the complex role of proteins in the onset, diagnosis, and treatment of cancer.
This research guide is best for:
- Scientists and professionals focused on oncology research.
- Proteomics, multiomics, and transcriptomics researchers.
- General scientific community.
Things you’ll learn about:
- The landscape of molecular oncology and proteomics.
- Targeted and untargeted methods for studying proteomics in oncology.
- Opportunities for unbiased, deep proteomics in cancer research.
- The Proteograph Product Suite’s unparallelled depth, scalability, and peptide-resolution capabilities for large cohort studies.
- Industry and academic applications, case studies, new data, and more.
Fill out form to download
Transform your research today!